Literature DB >> 11233874

The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.

F A McAlister1, N R Campbell, K Zarnke, M Levine, I D Graham.   

Abstract

Clinicians are exposed to numerous hypertension guidelines. However, their enthusiasm for these guidelines, and the impact of the guidelines, appears modest at best. Barriers to the successful implementation of a guideline can be identified at the level of the clinician, the patient or the practice setting; however, the shortcomings of the guidelines themselves have received little attention. In this paper, we review the hypertension guidelines that are most commonly encountered by Canadian clinicians: the "1999 Canadian Recommendations for the Management of Hypertension," "The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" in the United States and the "1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension." The key points of these guidelines are compared and the shortcomings that may impede their ability to influence practice are discussed. The main implications for future guideline developers are outlined.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233874      PMCID: PMC80782     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  42 in total

1.  The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review.

Authors:  G Worrall; P Chaulk; D Freake
Journal:  CMAJ       Date:  1997-06-15       Impact factor: 8.262

2.  Consumer/patient decision support in the new millennium: where should our research take us?

Authors:  A M O'Connor
Journal:  Can J Nurs Res       Date:  1997

3.  Canadian physicians' attitudes about and preferences regarding clinical practice guidelines.

Authors:  R S Hayward; G H Guyatt; K A Moore; K A McKibbon; A O Carter
Journal:  CMAJ       Date:  1997-06-15       Impact factor: 8.262

Review 4.  Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines.

Authors:  D A Davis; A Taylor-Vaisey
Journal:  CMAJ       Date:  1997-08-15       Impact factor: 8.262

Review 5.  Towards a better yardstick: the choice of treatment thresholds in hypertension.

Authors:  F A McAlister; A Laupacis
Journal:  Can J Cardiol       Date:  1998-01       Impact factor: 5.223

6.  Awareness, treatment, and control of hypertension in Canada.

Authors:  M R Joffres; P Ghadirian; J G Fodor; A Petrasovits; A Chockalingam; P Hamet
Journal:  Am J Hypertens       Date:  1997-10       Impact factor: 2.689

7.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

8.  Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  D Siegel; J Lopez
Journal:  JAMA       Date:  1997-12-03       Impact factor: 56.272

9.  A survey of clinician attitudes and management practices in hypertension.

Authors:  F A McAlister; A Laupacis; K K Teo; P G Hamilton; T J Montague
Journal:  J Hum Hypertens       Date:  1997-07       Impact factor: 3.012

10.  Guidelines on anticoagulant treatment in atrial fibrillation in Great Britain: variation in content and implications for treatment.

Authors:  R Thomson; H McElroy; M Sudlow
Journal:  BMJ       Date:  1998-02-14
View more
  18 in total

1.  Take a lesson from the drug companies.

Authors:  D Roth
Journal:  CMAJ       Date:  2001-08-07       Impact factor: 8.262

2.  The Canadian Hypertension Education Program--a unique Canadian initiative.

Authors:  F A McAlister
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

3.  The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.

Authors:  Finlay A McAlister; Eric Wooltorton; Norman R C Campbell
Journal:  CMAJ       Date:  2005-08-30       Impact factor: 8.262

Review 4.  Resource Effective Strategies to Prevent and Treat Cardiovascular Disease.

Authors:  J D Schwalm; Martin McKee; Mark D Huffman; Salim Yusuf
Journal:  Circulation       Date:  2016-02-23       Impact factor: 29.690

Review 5.  Choices and goals in the treatment of the diabetic hypertensive patient.

Authors:  E Basta; G Bakris
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

6.  Identifying performance indicators for family practice: assessing levels of consensus.

Authors:  Jan Barnsley; Whitney Berta; Rhonda Cockerill; Judith MacPhail; Eugene Vayda
Journal:  Can Fam Physician       Date:  2005-05       Impact factor: 3.275

Review 7.  Treatment and blood pressure control in 47,964 people with diabetes and hypertension: a systematic review of observational studies.

Authors:  Donna L McLean; Scot H Simpson; Finlay A McAlister; Ross T Tsuyuki
Journal:  Can J Cardiol       Date:  2006-08       Impact factor: 5.223

8.  Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study.

Authors:  J M Cavazos; A D Naik; A Woofter; N S Abraham
Journal:  Aliment Pharmacol Ther       Date:  2008-09-15       Impact factor: 8.171

9.  The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.

Authors:  Finlay A McAlister; Cynthia Robitaille; Cathleen Gillespie; Keming Yuan; Deepa P Rao; Steven Grover; Sulan Dai; Helen Johansen; Michel Joffres; Fleetwood Loustalot; Norm Campbell
Journal:  Can J Cardiol       Date:  2013-03-01       Impact factor: 5.223

Review 10.  Hypertension in children and adolescents: epidemiology and natural history.

Authors:  Bonita Falkner
Journal:  Pediatr Nephrol       Date:  2009-05-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.